Cargando…
An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells
Human pluripotent stem cells (hPSCs) represent a unique opportunity for understanding the molecular mechanisms underlying complex traits and diseases. CRISPR/Cas9 is a powerful tool to introduce genetic mutations into the hPSCs for loss-of-function studies. Here, we developed an episomal vector-base...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443789/ https://www.ncbi.nlm.nih.gov/pubmed/28539611 http://dx.doi.org/10.1038/s41598-017-02456-y |
_version_ | 1783238619060764672 |
---|---|
author | Xie, Yifang Wang, Daqi Lan, Feng Wei, Gang Ni, Ting Chai, Renjie Liu, Dong Hu, Shijun Li, Mingqing Li, Dajin Wang, Hongyan Wang, Yongming |
author_facet | Xie, Yifang Wang, Daqi Lan, Feng Wei, Gang Ni, Ting Chai, Renjie Liu, Dong Hu, Shijun Li, Mingqing Li, Dajin Wang, Hongyan Wang, Yongming |
author_sort | Xie, Yifang |
collection | PubMed |
description | Human pluripotent stem cells (hPSCs) represent a unique opportunity for understanding the molecular mechanisms underlying complex traits and diseases. CRISPR/Cas9 is a powerful tool to introduce genetic mutations into the hPSCs for loss-of-function studies. Here, we developed an episomal vector-based CRISPR/Cas9 system, which we called epiCRISPR, for highly efficient gene knockout in hPSCs. The epiCRISPR system enables generation of up to 100% Insertion/Deletion (indel) rates. In addition, the epiCRISPR system enables efficient double-gene knockout and genomic deletion. To minimize off-target cleavage, we combined the episomal vector technology with double-nicking strategy and recent developed high fidelity Cas9. Thus the epiCRISPR system offers a highly efficient platform for genetic analysis in hPSCs. |
format | Online Article Text |
id | pubmed-5443789 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-54437892017-05-26 An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells Xie, Yifang Wang, Daqi Lan, Feng Wei, Gang Ni, Ting Chai, Renjie Liu, Dong Hu, Shijun Li, Mingqing Li, Dajin Wang, Hongyan Wang, Yongming Sci Rep Article Human pluripotent stem cells (hPSCs) represent a unique opportunity for understanding the molecular mechanisms underlying complex traits and diseases. CRISPR/Cas9 is a powerful tool to introduce genetic mutations into the hPSCs for loss-of-function studies. Here, we developed an episomal vector-based CRISPR/Cas9 system, which we called epiCRISPR, for highly efficient gene knockout in hPSCs. The epiCRISPR system enables generation of up to 100% Insertion/Deletion (indel) rates. In addition, the epiCRISPR system enables efficient double-gene knockout and genomic deletion. To minimize off-target cleavage, we combined the episomal vector technology with double-nicking strategy and recent developed high fidelity Cas9. Thus the epiCRISPR system offers a highly efficient platform for genetic analysis in hPSCs. Nature Publishing Group UK 2017-05-24 /pmc/articles/PMC5443789/ /pubmed/28539611 http://dx.doi.org/10.1038/s41598-017-02456-y Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Xie, Yifang Wang, Daqi Lan, Feng Wei, Gang Ni, Ting Chai, Renjie Liu, Dong Hu, Shijun Li, Mingqing Li, Dajin Wang, Hongyan Wang, Yongming An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells |
title | An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells |
title_full | An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells |
title_fullStr | An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells |
title_full_unstemmed | An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells |
title_short | An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells |
title_sort | episomal vector-based crispr/cas9 system for highly efficient gene knockout in human pluripotent stem cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443789/ https://www.ncbi.nlm.nih.gov/pubmed/28539611 http://dx.doi.org/10.1038/s41598-017-02456-y |
work_keys_str_mv | AT xieyifang anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT wangdaqi anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT lanfeng anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT weigang anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT niting anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT chairenjie anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT liudong anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT hushijun anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT limingqing anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT lidajin anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT wanghongyan anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT wangyongming anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT xieyifang episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT wangdaqi episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT lanfeng episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT weigang episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT niting episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT chairenjie episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT liudong episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT hushijun episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT limingqing episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT lidajin episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT wanghongyan episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells AT wangyongming episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells |